CD30 positive (non-anaplastic) peripheral T cell lymphoma of the thyroid gland

Haematologica

Volumn 84, Issue 10, 1999, Pages 946-948

  Forconi, Francesco ^a   Bocchia, Monica ^b   Marconcini, Silvia ^b   Bigazzi, Catia ^b   Milani, Marina ^b   Fraternali Orcioni, Giulio ^b   Lauria, Francesco ^b  

^a Ospedale A Sclavo   (Italy)

^b NONE

Author keywords

ALK1; CD30; NHL; Non anaplastic; Thyroid

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; REED STERNBERG CELL; T CELL LYMPHOMA; THYROID CANCER;

ADULT; ANTIGENS, CD30; CELL SIZE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, PERIPHERAL; THYROID NEOPLASMS;

EID: 0032743624     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Burke JS. Waldayer's ring, sinusal region, salivary gland, thyroid gland, central nervous system, and other extranodal lymphomas and lymphoid hyperplasias. In: Knowles DM, ed. Neoplastic hemopathology. Baltimore: Williams and Wilkins, 1992. p. 1047-79.
2. Pedersen RK, Pedersen NT. Primary non-Hodgkin's lymphoma of the thyroid gland: a population based study. Histopathology 1996; 28:25-32.
3. Pledge S, Bessell EM, Leach IH, et al. Non Hodgkin's lymphomas of the thyroid gland: a population based study. Histopathology 1996; 28:25-32.
4. Harris NL, Jaffe ES, Stein H, et al. A Revised European-American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
5. Compagno J, Oertel JE. Malignant lymphoma and other lymphoproliferative disorders of the thyroid gland. A clinicopathologic study of 245 cases. Am J Clin Pathol 1980; 74:1-11.
6. Staunton MD, Greening WP. Clinical diagnosis of thyroid cancer. BMJ 1973; 4:532-5.
7. Ohsawa M, Aozasa K, Saeki K, Tsujimura T, Tamai M, Kawano K. Distribution of histologic subtypes and sex ratio in various primary sites of lymphocytic lymphoma. J Surg Oncol 1992; 49:127-30.
8. Freeman C, Berg CW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29: 252-60.
9. D'Amore F, Christensen BE, Brincker H, et al. Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphoma. Danish LYFO Study Group. Eur J Cancer 1991; 27:1201-8.
10. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984; 53:2515-24.
11. Logue JP, Hale RJ, Stewart AL, Duthie MB, Banerjee SS. Primary malignant lymphoma of the thyroid. A clinicopathological analysis. Int J Radiat Oncol Biol Phys 1992; 22:929-33.
12. Anscombe AM, Wright DH. Primary malignant lymphoma of the thyroid - a tumor of mucosa-associated lymphoid tissue: review of 76 cases. Histopathology 1985; 9:81-97.
13. Mizukami Y, Michigishi T, Nonomura A, et al. Primary lymphoma of the thyroid: a clinical, histological and immunohistochemical study of 20 cases. Histopathology 1990; 17:201-9.
14. Rosen IB, Sutcliffe SB, Gospodarowicz MK, Chua T, Simpson WJ. The role of surgery in the management of thyroid lymphoma. Surgery 1988; 104:1095-9.
15. Vigliotti A, Kong JS, Fuller LM, Velasquez WS. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment. Int J Radiat Oncol Biol Phys 1986; 12:1807-12.
16. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B cell mucosaassociated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990; 136:1153-64.
17. Hyjek E, Isaacson PG et al. Primary B-cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988; 19:1315-26.
18. Abdul-Rahman ZH, Gogas HJ, Tooze JA, et al. T-cell lymphoma in Hashimoto's thyroiditis. Histopathology 1996; 29:455-9.
19. Matsuzuka F, Miyauchi A, Katayama S, et al. Clinical aspects of primary thyroid lymphomas: diagnosis and treatment based on our experience of 119 cases. Thyroid 1993; 3:93-9.
20. Clark OH. Fine needle aspiration biopsy and management of thyroid tumors. Am J Clin Pathol 1997; 108:(Suppl 1):S22-5.
21. Godinho-Matos L, Kocjan G, Kurtz A. Contribution of fine-needle aspiration cytology to management of thyroid disease. J Clin Pathol 1992; 45:391-5.
22. De Bruin PC, Gruss HJ, Van der Valk P, Willemze R, Meijer CJ. CD30 expression in normal and neoplastic lymphoid tissue: biologic aspects and clinical implications. Leukemia 1995; 9:1620-7.
23. Piris M, Brown DC, Gatter KC, Mason DY. CD30 expression in non-Hodgkin's lymphoma. Histopathology 1990; 17:211-8.
24. Pulford K, Lamant L, Morris SW, et al. Detection of ALK and NPM-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997; 89:1394-404.
25. Rimokh R, Magaud JP, Berger F, et al. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Haematol 1989; 74:161.
26. Bennharroch D, Meguerina-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998; 91:2076-84.
27. Cabanillas F, Romanguerra J, Manning J. Ki-1 positive large cell lymphoma: is it a clinical entity? [abstract] Paper presented at the Fifth International Conference on Malignant Lymphomas. Lugano, 1993:10.
28. Chang SN, Kim HS, Kim DK, Yang WI. Primary cutaneous Ki-1-positive large cell lymphoma: nonanaplastic type showing repeated spontaneous regression. J Am Acad Dermatol 1996; 35:470-2.
29. Marzano AV, Alessi E, Berti E. CD30-positive multilobated T-cell lymphoma primarily involving the subcutaneous tissue. Am J Dermatopathol 1997; 19:284-8.
30. Paulli M, Rosso R, Kindl S, et al. Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas. A clinicopathologic analysis of six cases. Cancer 1994; 73:541-9.